S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

ARQT

Arcutis Biotherapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
23.90
+0.24 +1.01%
USD · close Sep 4
MKT CAP $3BP/E 113.8DIV YIELD FCF YIELD 1.30%REV TTM $464M +76.1%NET INCOME $28.5MNET DEBT $74.8M52W 16.73 – 31.20NEXT EARNINGS Oct 27SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
TradedDisclosedLagMemberTypeAmountFiling
May 29Jun 810dGilbert Cisneros D·CABuy$1K–$15Ksource ↗
Mar 3Apr 735dGilbert Cisneros D·CABuy$1K–$15Ksource ↗
Dec 11Jan 1232dGilbert Cisneros D·CASell$1K–$15Ksource ↗

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch ARQT. Know when insiders buy.
One email the day a filing lands. Free.